These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 23219077

  • 1. Cardiovascular involvement in patients affected by acromegaly: an appraisal.
    Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, Parente A, Conte S, Rengo G, Leosco D, Trimarco B, Filardi PP.
    Int J Cardiol; 2013 Sep 01; 167(5):1712-8. PubMed ID: 23219077
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular complications in acromegaly.
    Vitale G, Pivonello R, Lombardi G, Colao A.
    Minerva Endocrinol; 2004 Sep 01; 29(3):77-88. PubMed ID: 15282442
    [Abstract] [Full Text] [Related]

  • 6. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M, Giustina A, Manelli F, Cicoira MA, Lorusso R, Giordano A.
    Ital Heart J; 2000 Nov 01; 1(11):732-8. PubMed ID: 11110515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acromegaly and Heart Failure.
    Colao A, Grasso LFS, Di Somma C, Pivonello R.
    Heart Fail Clin; 2019 Jul 01; 15(3):399-408. PubMed ID: 31079698
    [Abstract] [Full Text] [Related]

  • 9. 5 Long-term acromegaly and associated cardiovascular complications: a case-based review.
    Colao A.
    Best Pract Res Clin Endocrinol Metab; 2009 Dec 01; 23 Suppl 1():S31-8. PubMed ID: 20129192
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN, Comninos AN, Clarke H, Donaldson M, Meeran K, Dhillo WS.
    Clin Endocrinol (Oxf); 2011 Aug 01; 75(2):220-5. PubMed ID: 21521288
    [Abstract] [Full Text] [Related]

  • 12. Acromegaly and the cardiovascular system.
    Lombardi G, Galdiero M, Auriemma RS, Pivonello R, Colao A.
    Neuroendocrinology; 2006 Aug 01; 83(3-4):211-7. PubMed ID: 17047385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S, Gasco V, Ragazzoni F, Ghigo E.
    J Endocrinol Invest; 2003 Aug 01; 26(10 Suppl):27-35. PubMed ID: 15497657
    [Abstract] [Full Text] [Related]

  • 16. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A, Terzolo M, Bondanelli M, Galderisi M, Vitale G, Reimondo G, Ambrosio MR, Pivonello R, Lombardi G, Angeli A, degli Uberti EC.
    Clin Endocrinol (Oxf); 2008 Oct 01; 69(4):613-20. PubMed ID: 18410555
    [Abstract] [Full Text] [Related]

  • 17. [Heart disease in acromegaly. Study of 27 patients].
    Marín F, Picó AM, Martínez JG, Domínguez JR, Alfayete R, Sogorb F.
    Med Clin (Barc); 1996 Sep 21; 107(9):326-30. PubMed ID: 8984234
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The heart: an end-organ of GH action.
    Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G.
    Eur J Endocrinol; 2004 Aug 21; 151 Suppl 1():S93-101. PubMed ID: 15339252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.